COMBAT - A Combination B-and T-Cell Epitope Vaccine to Futureproof COVID-19 Vaccine

We are proposing a vaccine that contains only safe components of the SARS-CoV-2 virus, yet effectively elicits protective immunity. The vaccine works by inducing antibodies capable of preventing the virus from attaching to lung cells, and killer T cells that destroy virus-infected cells. This highly innovative approach will generate a much needed safe and prophylactic 2nd generation modular vaccine, ideal for "vaccine update" that will have a major impact on health and society more generally.